Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Thomas

Showing results (161-170 of 398) with videos related to

Pageof 40
Sort By:
Lancet (London, England)|December 28, 1999
Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative ResearchM Thursz, R Yallop, R Goldin, et al.
Lancet (London, England)|February 11, 1978
In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravisA Vincent, G K Scadding, H C Thomas, et al.
British Medical Journal (Clinical Research Ed.)|January 24, 1981
Primary liver cell cancer in autoimmune chronic liver diseaseA K Burroughs, M F Bassendine, H C Thomas, et al.
Journal of Medical Virology|January 1, 1984
The removal of hepatitis B virus from factor VIII concentrates by fractionation on ethylene maleic anhydride polyelectrolyteS A Galpin, P Karayiannis, S M Middleton, et al.
Journal of Hepatology|July 1, 1991
Serum HBV DNA detected by PCR in dot blot negative HBV chronic carriers with active liver diseaseJ Monjardino, J Velosa, H C Thomas, et al.
British Journal of Haematology|June 1, 1989
Interferon therapy for chronic non-A non-B and chronic delta liver disease in haemophiliaC A Lee, P B Kernoff, P Karayiannis, et al.
Journal of Clinical Pathology|May 1, 1973
Food antibodies in oral disease: a study of serum antibodies to food proteins in aphthous ulceration and other oral diseasesH C Thomas, A Ferguson, J G McLennan, et al.
British Journal of Haematology|July 1, 1985
High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulinP B Kernoff, C A Lee, P Karayiannis, et al.
Journal of Viral Hepatitis|March 1, 1996
The expression of hepatitis B virus polymerase in hepatocytes during chronic HBV infectionM J McGarvey, R D Goldin, P Karayiannis, et al.
BMJ (Clinical Research Ed.)|September 3, 1999
Increased mortality from liver cancer in England and Wales is not related to hepatitis CS D Taylor-Robinson, H C Thomas, S Arora, et al.
Pageof 40

Showing results (161-170 of 398) with videos related to

Sort By:
Pageof 40
Lancet (London, England)|December 28, 1999
Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative ResearchM Thursz, R Yallop, R Goldin, et al.
Lancet (London, England)|February 11, 1978
In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravisA Vincent, G K Scadding, H C Thomas, et al.
British Medical Journal (Clinical Research Ed.)|January 24, 1981
Primary liver cell cancer in autoimmune chronic liver diseaseA K Burroughs, M F Bassendine, H C Thomas, et al.
Journal of Medical Virology|January 1, 1984
The removal of hepatitis B virus from factor VIII concentrates by fractionation on ethylene maleic anhydride polyelectrolyteS A Galpin, P Karayiannis, S M Middleton, et al.
Journal of Hepatology|July 1, 1991
Serum HBV DNA detected by PCR in dot blot negative HBV chronic carriers with active liver diseaseJ Monjardino, J Velosa, H C Thomas, et al.
British Journal of Haematology|June 1, 1989
Interferon therapy for chronic non-A non-B and chronic delta liver disease in haemophiliaC A Lee, P B Kernoff, P Karayiannis, et al.
Journal of Clinical Pathology|May 1, 1973
Food antibodies in oral disease: a study of serum antibodies to food proteins in aphthous ulceration and other oral diseasesH C Thomas, A Ferguson, J G McLennan, et al.
British Journal of Haematology|July 1, 1985
High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulinP B Kernoff, C A Lee, P Karayiannis, et al.
Journal of Viral Hepatitis|March 1, 1996
The expression of hepatitis B virus polymerase in hepatocytes during chronic HBV infectionM J McGarvey, R D Goldin, P Karayiannis, et al.
BMJ (Clinical Research Ed.)|September 3, 1999
Increased mortality from liver cancer in England and Wales is not related to hepatitis CS D Taylor-Robinson, H C Thomas, S Arora, et al.
Pageof 40